Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OSIR > SEC Filings for OSIR > Form 8-K on 3-Jun-2013All Recent SEC Filings

Show all filings for OSIRIS THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro



Submission of Matters to a Vote of Security Holders


Osiris Therapeutics, Inc. held its Annual Meeting of Stockholders on May 30, 2013. Of the 32,930,429 shares of common stock outstanding as of the record date of the Annual Meeting, 23,570,772 shares, or 71.6% of the total shares eligible to vote at the Annual Meeting, were represented in person or by proxy. Two proposals were submitted to the stockholders and approved at the Annual Meeting. The proposals are described in detail in our previously filed Proxy Statement for the Annual Meeting. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for or against each matter and the number of abstentions and broker non-votes with respect to each matter, both in person and by proxy.

Election of Two Directors. Jay M. Moyes and Hans-Georg Klingemann were elected to serve as members of the board of directors for a term expiring at the Annual Meeting of Stockholders to be held in 2016 and until their respective successors are duly elected and qualified, as follows:

Director                Votes FOR    Votes WITHHELD
Jay M. Moyes            20,427,677          161,052
Hans-Georg Klingemann   20,475,728          113,001

The term of office of each of Peter Friedli, Felix Gutzwiller, and C. Randal Mills continued following the meeting.

Ratify Independent Registered Public Accountants. The appointment of Grant Thornton LLP, independent registered public accountants, to act as our independent auditors for the fiscal year ending December 31, 2013 was ratified, as follows:

FOR       23,484,078
AGAINST       61,368
ABSTAIN       25,326

Information presented in this Current Report on Form 8-K may contain forward-looking statements and certain assumptions upon which such forward-looking statements are in part based. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Risks and that could cause actual results to differ materially from those anticipated in forward-looking statements, include the factors described in the sections entitled "Risk Factors" in our Annual Report on Form 10-K filed with the United States Securities and Exchange. You should not unduly rely on forward-looking statements.

  Add OSIR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OSIR - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.